Clinical Trials Logo

Acquired Pure Red Cell Aplasia clinical trials

View clinical trials related to Acquired Pure Red Cell Aplasia.

Filter by:
  • None
  • Page 1

NCT ID: NCT04423367 Recruiting - Clinical trials for Acquired Pure Red Cell Aplasia

Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment

BID-PERAL
Start date: September 13, 2020
Phase: Phase 2
Study type: Interventional

This is an open-label, single-arm study to evaluate the safety and efficacy of bortezomib plus dexamethasone for acquired pure red cell aplasia failure or relapse after first-line treatment.